全球免疫组织化学市场 2024-2028

免疫组织化学市场预计在 2022-2027 年期间成长 10.6713 亿美元，预测期内复合年增长率为 7.52%。

该报告包括对免疫组织化学市场的总体分析、市场规模/预测、趋势、成长驱动因素、挑战以及涵盖约 25 家供应商的供应商分析。

它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场的推动因素包括全球癌症患者数量的增加、人口老化的加剧以及参与企业之间的併购。

该研究认为免疫组织化学过程的自动化和数数位化是未来几年推动免疫组织化学市场成长的关键因素之一。此外，个人化医疗需求的成长和医疗保健产业投资的增加也将带来巨大的市场需求。

目录

第一章执行摘要

• 市场概况

第二章 市场状况

• 市场生态系统

第三章 市场规模评估

• 市场定义
• 细分市场分析
• 2023 年市场规模
• 2023-2028年市场展望

第四章 市场规模表现

• 2018-2018年全球免疫组织化学市场
• 2018-2018 年按应用分類的细分市场分析
• 2018-2018 年最终用户細項分析
• 2018-2018年区域細項分析
• 2018-2018 年国家細項分析

第五章五力分析

• 五力摘要
• 买方议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

第六章市场区隔：按应用

• 细分市场
• 比较：按应用
• 诊断应用：2023-2028 年市场规模与预测
• 研究应用：2023-2028 年市场规模与预测
• 法医学应用：2023-2028 年市场规模与预测
• 市场机会：依应用分类

第七章市场区隔：依最终用户

• 细分市场
• 比较：按最终用户
• 医院与诊断实验室：2023-2028 年市场规模与预测
• 学术研究院：2023-2028年市场规模及预测
• 其他：2023-2028年市场规模与预测
• 市场机会：依最终用户划分

第八章 客户状况

• 客户状况概览

第九章 地区情势

• 区域细分
• 区域比较
• 北美：2023-2028 年市场规模与预测
• 欧洲：2023-2028 年市场规模与预测
• 亚洲：2023-2028年市场规模与预测
• 世界其他地区：2023-2028 年市场规模与预测
• 美国：2023-2028 年市场规模与预测
• 德国：2023-2028 年市场规模与预测
• 法国：2023-2028年市场规模与预测
• 中国：2023-2028年市场规模及预测
• 英国：2023-2028 年市场规模与预测
• 市场机会：依地区状况

第 10 章 驱动因素、挑战与趋势

• 市场驱动因素
• 市场挑战
• 驱动因素和挑战的影响
• 市场趋势

第十一章 供应商情况

• 概述
• 供应商情况
• 混乱的情况
• 产业风险

第十二章供应商分析

• 交易厂商
• 供应商市场定位
• Agilent Technologies Inc.
• Bio SB
• Biocare Medical LLC
• BioGenex Laboratories Inc.
• CANDOR Bioscience GmbH
• Cell Signaling Technology Inc.
• Danaher Corp.
• Elabscience Biotechnology Inc.
• F. Hoffmann La Roche Ltd.
• Lunaphore Technologies SA
• Merck KGaA
• Miltenyi Biotec BV and Co. KG
• SAKURA SEIKI Co. Ltd.
• Takara Holdings Inc.
• Thermo Fisher Scientific Inc.

第十三章附录

The immunohistochemistry market is forecasted to grow by USD 1,067.13 mn during 2022-2027, accelerating at a CAGR of 7.52% during the forecast period. The report on the immunohistochemistry market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing number of cancer patients globally, the rising aging population, and mergers and acquisitions among immunohistochemistry market players.

Technavio's immunohistochemistry market is segmented as below:

By Application

• Diagnostic application
• Research application
• Forensic application

By End-user

• Hospitals and diagnostic laboratories
• Academic and research institutes
• Others

By Geographical Landscape

• North America
• Europe
• APAC
• Rest of World (ROW)

This study identifies the automation and digitalization of immunohistochemistry processes as one of the prime reasons driving the immunohistochemistry market growth during the next few years. Also, rise in demand for personalized medicine and increasing investment in healthcare industry will lead to sizable demand in the market.

The report on the immunohistochemistry market covers the following areas:

• Immunohistochemistry market sizing
• Immunohistochemistry market forecast
• Immunohistochemistry market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunohistochemistry market vendors that include Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio SB, Bio Techne Corp., Biocare Medical LLC, BioGenex Laboratories Inc., CANDOR Bioscience GmbH, Cell Signaling Technology Inc., Danaher Corp., Eagle Biosciences Inc., Elabscience Biotechnology Inc., F. Hoffmann La Roche Ltd., Lunaphore Technologies SA, Merck KGaA, Miltenyi Biotec B.V. and Co. KG, PerkinElmer Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., PHC Holdings Corp., and SAKURA SEIKI Co. Ltd.. Also, the immunohistochemistry market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global immunohistochemistry market 2018 - 2018
• 4.2 Application Segment Analysis 2018 - 2018
• 4.3 End-user Segment Analysis 2018 - 2018
• 4.4 Geography Segment Analysis 2018 - 2018
• 4.5 Country Segment Analysis 2018 - 2018

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Application

• 6.1 Market segments
• 6.2 Comparison by Application
• 6.3 Diagnostic application - Market size and forecast 2023-2028
• 6.4 Research application - Market size and forecast 2023-2028
• 6.5 Forensic application - Market size and forecast 2023-2028
• 6.6 Market opportunity by Application

7 Market Segmentation by End-user

• 7.1 Market segments
• 7.2 Comparison by End-user
• 7.3 Hospitals and diagnostic laboratories - Market size and forecast 2023-2028
• 7.4 Academic and research institutes - Market size and forecast 2023-2028
• 7.5 Others - Market size and forecast 2023-2028
• 7.6 Market opportunity by End-user

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 Germany - Market size and forecast 2023-2028
• 9.9 France - Market size and forecast 2023-2028
• 9.10 China - Market size and forecast 2023-2028
• 9.11 UK - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Agilent Technologies Inc.
• 12.4 Bio SB
• 12.5 Biocare Medical LLC
• 12.6 BioGenex Laboratories Inc.
• 12.7 CANDOR Bioscience GmbH
• 12.8 Cell Signaling Technology Inc.
• 12.9 Danaher Corp.
• 12.10 Elabscience Biotechnology Inc.
• 12.11 F. Hoffmann La Roche Ltd.
• 12.12 Lunaphore Technologies SA
• 12.13 Merck KGaA
• 12.14 Miltenyi Biotec B.V. and Co. KG
• 12.15 SAKURA SEIKI Co. Ltd.
• 12.16 Takara Holdings Inc.
• 12.17 Thermo Fisher Scientific Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global immunohistochemistry market 2018 - 2018 ($ billion)
• Exhibits19: Historic Market Size - Application Segment 2018 - 2018 ($ billion)
• Exhibits20: Historic Market Size - End-user Segment 2018 - 2018 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2018 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2018 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Application - Market share 2023-2028 (%)
• Exhibits31: Data Table on Application - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Application
• Exhibits33: Data Table on Comparison by Application
• Exhibits34: Chart on Diagnostic application - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Data Table on Diagnostic application - Market size and forecast 2023-2028 ($ billion)
• Exhibits36: Chart on Diagnostic application - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Diagnostic application - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Research application - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Data Table on Research application - Market size and forecast 2023-2028 ($ billion)
• Exhibits40: Chart on Research application - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Research application - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Forensic application - Market size and forecast 2023-2028 ($ billion)
• Exhibits43: Data Table on Forensic application - Market size and forecast 2023-2028 ($ billion)
• Exhibits44: Chart on Forensic application - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Forensic application - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by Application ($ billion)
• Exhibits47: Data Table on Market opportunity by Application ($ billion)
• Exhibits48: Chart on End-user - Market share 2023-2028 (%)
• Exhibits49: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by End-user
• Exhibits51: Data Table on Comparison by End-user
• Exhibits52: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
• Exhibits53: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
• Exhibits54: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
• Exhibits57: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
• Exhibits58: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits62: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits64: Market opportunity by End-user ($ billion)
• Exhibits65: Data Table on Market opportunity by End-user ($ billion)
• Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits69: Chart on Geographic comparison
• Exhibits70: Data Table on Geographic comparison
• Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits97: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits107: Market opportunity By Geographical Landscape ($ billion)
• Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits109: Impact of drivers and challenges in 2023 and 2028
• Exhibits110: Overview on Criticality of inputs and Factors of differentiation
• Exhibits111: Overview on factors of disruption
• Exhibits112: Impact of key risks on business
• Exhibits113: Vendors covered
• Exhibits114: Matrix on vendor position and classification
• Exhibits115: Agilent Technologies Inc. - Overview
• Exhibits116: Agilent Technologies Inc. - Business segments
• Exhibits117: Agilent Technologies Inc. - Key news
• Exhibits118: Agilent Technologies Inc. - Key offerings
• Exhibits119: Agilent Technologies Inc. - Segment focus
• Exhibits120: Bio SB - Overview
• Exhibits121: Bio SB - Product / Service
• Exhibits122: Bio SB - Key offerings
• Exhibits123: Biocare Medical LLC - Overview
• Exhibits124: Biocare Medical LLC - Product / Service
• Exhibits125: Biocare Medical LLC - Key offerings
• Exhibits126: BioGenex Laboratories Inc. - Overview
• Exhibits127: BioGenex Laboratories Inc. - Product / Service
• Exhibits128: BioGenex Laboratories Inc. - Key offerings
• Exhibits129: CANDOR Bioscience GmbH - Overview
• Exhibits130: CANDOR Bioscience GmbH - Product / Service
• Exhibits131: CANDOR Bioscience GmbH - Key offerings
• Exhibits132: Cell Signaling Technology Inc. - Overview
• Exhibits133: Cell Signaling Technology Inc. - Product / Service
• Exhibits134: Cell Signaling Technology Inc. - Key offerings
• Exhibits135: Danaher Corp. - Overview
• Exhibits136: Danaher Corp. - Business segments
• Exhibits137: Danaher Corp. - Key news
• Exhibits138: Danaher Corp. - Key offerings
• Exhibits139: Danaher Corp. - Segment focus
• Exhibits140: Elabscience Biotechnology Inc. - Overview
• Exhibits141: Elabscience Biotechnology Inc. - Product / Service
• Exhibits142: Elabscience Biotechnology Inc. - Key offerings
• Exhibits143: F. Hoffmann La Roche Ltd. - Overview
• Exhibits144: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits145: F. Hoffmann La Roche Ltd. - Key news
• Exhibits146: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits147: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits148: Lunaphore Technologies SA - Overview
• Exhibits149: Lunaphore Technologies SA - Product / Service
• Exhibits150: Lunaphore Technologies SA - Key offerings
• Exhibits151: Merck KGaA - Overview
• Exhibits152: Merck KGaA - Business segments
• Exhibits153: Merck KGaA - Key news
• Exhibits154: Merck KGaA - Key offerings
• Exhibits155: Merck KGaA - Segment focus
• Exhibits156: Miltenyi Biotec B.V. and Co. KG - Overview
• Exhibits157: Miltenyi Biotec B.V. and Co. KG - Product / Service
• Exhibits158: Miltenyi Biotec B.V. and Co. KG - Key offerings
• Exhibits159: SAKURA SEIKI Co. Ltd. - Overview
• Exhibits160: SAKURA SEIKI Co. Ltd. - Product / Service
• Exhibits161: SAKURA SEIKI Co. Ltd. - Key offerings
• Exhibits162: Takara Holdings Inc. - Overview
• Exhibits163: Takara Holdings Inc. - Business segments
• Exhibits164: Takara Holdings Inc. - Key offerings
• Exhibits165: Takara Holdings Inc. - Segment focus
• Exhibits166: Thermo Fisher Scientific Inc. - Overview
• Exhibits167: Thermo Fisher Scientific Inc. - Business segments
• Exhibits168: Thermo Fisher Scientific Inc. - Key news
• Exhibits169: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits170: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits171: Inclusions checklist
• Exhibits172: Exclusions checklist
• Exhibits173: Currency conversion rates for US$
• Exhibits174: Research methodology
• Exhibits175: Validation techniques employed for market sizing
• Exhibits176: Information sources
• Exhibits177: List of abbreviations